Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

610K_imputed - samples

ABSTRACT: 610k genotyping imputed on Hapmap 3 and 1000G Phase 1 CEU

PROVIDER: EGAD00010000704 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Publications

A multi-factorial analysis of response to warfarin in a UK prospective cohort.

Bourgeois Stephane S Jorgensen Andrea A Zhang Eunice J EJ Hanson Anita A Gillman Matthew S MS Bumpstead Suzannah S Toh Cheng Hock CH Williamson Paula P Daly Ann K AK Kamali Farhad F Deloukas Panos P Pirmohamed Munir M

Genome medicine 20160106 1

<h4>Background</h4>Warfarin is the most widely used oral anticoagulant worldwide, but it has a narrow therapeutic index which necessitates constant monitoring of anticoagulation response. Previous genome-wide studies have focused on identifying factors explaining variance in stable dose, but have not explored the initial patient response to warfarin, and a wider range of clinical and biochemical factors affecting both initial and stable dosing with warfarin.<h4>Methods</h4>A prospective cohort o ...[more]

PMID: 26739746

Similar Datasets

Genome-wide baseline microRNA expression quantification in HapMap phase I CEU and YRI samples

Project description:Baseline microRNA (miRNA) expression was evaluated in 107 HapMap lymphoblastoid cell lines (LCLs; 53 CEU and 54 YRI) using Exiqon miRCURY LNA arrays v10.0 (Exiqon array).

2012-07-29 | GSE34406 | GEO

Illumina HapMap CEU (1M-Duo)

Project description:HapMap CEU samples

2009-07-27 | GSE16894 | GEO

Custom array CGH validation of de novo CNVs in CEU HapMap samples

Project description:This is the validation data for candidate de novo CNV calls made in the CEU Hapmap by Itsara et al., Genome Research 2010. In this study, de novo CNV calls were initially made with Illumina 1M SNP arrays. Validation of CNV calls was performed with Nimblegen custom array CGH using the extended CEPH pedigrees. A truly de novo CNV would be unobserved in the first generation (CEU trio parents), validated in the second generation (CEU trio children), and assuming no selective effects, transmitted to approximately half of the individuals in the third generation. We attempted validation of 4 de novo CNVs in 3 extended CEPH pedigrees: 1358, 1408, and 1459.

2010-09-01 | GSE23575 | GEO

Individual-specific and allele-specific chromatin signatures in diverse human populations

Project description:This dataset contains DNase-seq data and CTCF ChIP-seq data for 6 lymphoblastoid cell lines. There are 3 cell lines from a YRI trio and 3 lines from a CEU trio (HapMap GM19238, GM19239, GM 19240, GM12891, GM12892, GM12878). For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODEDataReleasePolicyFinal2008.pdf

2010-03-15 | GSE19622 | GEO

ADME gene variants in multiple myeloma susceptibility

Project description:The metabolism of xenobiotics is regulated by phase I and II enzymes, and by transporters encoded by the absorption, distribution, metabolism, and excretion (ADME) genes. It is known that the activity of these proteins is influenced by the presence of polymorphic variants in the corresponding gene that can account for the inter-individual variability in both xenobiotic response/toxicity and disease predisposition. Exposure to pesticides and toxic substances, many of which are substrates of ADME-associated proteins, has been demonstrated to increase the risk of Multiple Myeloma (MM). To investigate the inter-individual variability of ADME genes as a risk factor for MM risk, we compared DMET Plus genotyping data from 65 MM patients with 59 CEU Hapmap controls (GPL17860).

2021-11-03 | GSE187009 | GEO

Genome-wide baseline microRNA expression quantification in HapMap phase I CEU and YRI samples

Project description:Baseline microRNA (miRNA) expression was evaluated in 107 HapMap lymphoblastoid cell lines (LCLs; 53 CEU and 54 YRI) using Exiqon miRCURY LNA arrays v10.0 (Exiqon array). Total RNA from each of the 107 HapMap sample was labeled and hybridized onto an Exiqon array

2012-07-28 | E-GEOD-34406 | biostudies-arrayexpress

CEU_RNASEQ60

Project description:RNA-sequencing of 60 HapMap CEU individuals

2010-06-01 | E-MTAB-197 | biostudies-arrayexpress

NSAID-LIV

Project description:1000G Phase 3 Imputed cases and controls from NSAID-induced PUD study

| EGAD00010001422 | EGA

Allelic Differences Account for Gene Expression Differences Among Population.

Project description:Expression level of genes in lymphoblasts from individuals in three HapMap populations (CEU, CHB, JPT) were compared. More than 1,000 genes were found to be significantly different (Pc<0.05) in mean expression level between the CEU and CHB+JPT samples. Keywords: Comparison of Gene Expression Profiles from Lymphoblastoid cells

2007-01-07 | GSE5859 | GEO

Individual-specific and allele-specific chromatin signatures in diverse human populations

2010-03-15 | E-GEOD-19622 | biostudies-arrayexpress